These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823 [TBL] [Abstract][Full Text] [Related]
8. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease. Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794 [TBL] [Abstract][Full Text] [Related]
9. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease. Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423 [TBL] [Abstract][Full Text] [Related]
10. Penicillamine should not be used as initial therapy in Wilson's disease. Brewer GJ Mov Disord; 1999 Jul; 14(4):551-4. PubMed ID: 10435490 [No Abstract] [Full Text] [Related]
11. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease. Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346 [TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis and treatment of Wilson's disease]. Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036 [TBL] [Abstract][Full Text] [Related]
16. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases. Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197 [TBL] [Abstract][Full Text] [Related]
17. Penicillamine induced pseudo-pseudoxanthoma elasticum in a patient with Wilson's disease, which role plays the hepatologist? Ibáñez-Samaniego L; Ochoa-Palominos A; Catalina-Rodríguez MV; Salcedo-Plaza M; Clemente-Ricote G Rev Esp Enferm Dig; 2015 Mar; 107(3):190-1. PubMed ID: 25733050 [No Abstract] [Full Text] [Related]
18. [Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years]. Boudin G; Pépin B; Milhaud M; Jérome H; Pacilly A Rev Neurol (Paris); 1968 Jan; 118(1):27-35. PubMed ID: 5697565 [No Abstract] [Full Text] [Related]
19. Penicillamine: the treatment of first choice for patients with Wilson's disease. Walshe JM Mov Disord; 1999 Jul; 14(4):545-50. PubMed ID: 10435489 [No Abstract] [Full Text] [Related]
20. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Hoogenraad TU Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]